Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
751.00    12.50 (1.69%)
Bid:
748.00
Ask:
751.00
Spread: 3.00 (0.401%)
Market Cap: £855.69m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Trading Update

25 Jan 2016 07:00

RNS Number : 7891M
Fevertree Drinks PLC
25 January 2016
 

25th January 2016

 

Fevertree Drinks plc ("Fever-Tree")

 

Trading update

 

Fever-Tree, the world's leading supplier of premium carbonated mixers, today announces its trading update for the year ended 31 December 2015.

 

The Board is pleased to announce that Fever-Tree has performed strongly in the second half of 2015. It is anticipated that sales in the second half will be ahead of the prior year period by 77%. Full year revenue is expected to be circa £59.2 million, reflecting growth of 71% on 2014.

 

Sales in the UK performed exceptionally well in the second half of 2015 and full year revenue is expected to be circa 84% ahead of 2014. Sales performance has been strong in both the On-Trade and Off-Trade channels, with notable growth achieved over the Christmas period against strong comparatives from 2014.

 

In the USA, the momentum seen in the first half continued during the second half of 2015 and as a result full year revenue is expected to be circa 65% ahead of 2014.

 

The strong sales growth in the Rest of Europe achieved in the first half accelerated in the second half of 2015 and it is anticipated that full year revenue will be circa 66% ahead of 2014.

 

Rest of World sales growth in the second half of 2015 remained strong and full year revenue is expected to be circa 50% ahead of 2014.

 

Over the period, Fever-Tree's free cash flow generation and balance sheet have remained strong. Year-end net cash position is anticipated to be in line with Board expectations, with significant cash balances still to collect given the strength of trading over the Christmas period.

 

FY15 expectations

 

Given the strong sales in the final two months of the year, the Board anticipates that the outcome for the full year will be comfortably ahead of its expectations.

 

Fever-Tree will announce its Preliminary Results on 14 March 2016.

 

Commenting on today's announcement, Tim Warrillow, CEO of Fever-Tree said:

 

"We are encouraged to report another positive trading statement. Fever-Tree continues to trade strongly, buoyed by a festive period significantly ahead of last year. We have continued to widen and deepen our penetration with growth across our product range in all our regions. We remain well positioned in our markets and look forward to the future with confidence."

 

UK Financial Reporting Notification

The Group's consolidated financial statements are prepared in accordance with IFRS as adopted by the EU. However, the accounting framework used for the Fevertree Drinks plc individual company accounts has been UK GAAP up to 31 December 2014. For the year ended 31 December 2015, the company is required by FRS 100 "Application of Financial reporting Requirements" to change its accounting framework. The Group intends to apply FRS 101 "Reduced Disclosure Framework" to the company accounts for the year ended 31 December 2015, which is not expected to give rise to any significant changes in disclosures. Shareholders holding more than 5% of the allotted shares of the company are entitled to object to the adoption of FRS 101. Objections should be made to the Company's registered office by 28 February 2016.

 

The Group's consolidated financial statements are unaffected by this change, and will continue to be prepared in accordance with IFRS as adopted by the EU.

 

 

For further information:

 

Fevertree Drinks plc

c/o FTI +44 (0)20 3727 1000

Tim Warrillow, Co-founder and CEO

Charles Rolls, Co-founder and Executive Deputy Chairman

Andy Branchflower, Finance Director

FTI Consulting - Financial PR

+44 (0)20 3727 1000

Jonathon Brill

fever-tree@fticonsulting.com

Oliver Winters

Tom Hufton

Investec Bank plc - Nominated Adviser and Broker

+44 (0)20 7597 4000

Garry Levin

Symmie Swill

Matt Lewis

David Anderson

 

Notes to Editors:

 

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 50 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade"). Approximately 70 per cent of the Group's sales were derived from outside of the UK in financial year 2015, with key overseas markets in the US and Europe.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFERLDIFFIR
Date   Source Headline
3rd Nov 20257:00 amRNSTotal Voting Rights
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20253:35 pmRNSDirector/PDMR Shareholding
17th Oct 20251:19 pmRNSResults of General Meeting
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20254:25 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20253:06 pmRNSTR-1: Notification of major holdings
1st Oct 20258:27 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20259:39 amRNSHolding(s) in Company
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 202512:03 pmRNSDirector/PDMR Shareholding
11th Sep 20258:00 amRNSProposed Share Premium Cancellation
11th Sep 20257:00 amRNSFY25 Interim Results to 30 June 2025
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20255:08 pmRNSHolding(s) in Company
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.